RecallDepth
Class III Ongoing

Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.

This recall is currently active, issued June 18, 2025. It was issued by Macleods Pharmaceuticals Ltd.

Company
Macleods Pharmaceuticals Ltd
Recall Initiated
May 29, 2025
Posted
June 18, 2025
Recall Number
D-0470-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,344- 1000 count bottles
Firm Location
Mumbai, India
Official Source
View on FDA website ↗

Reason for Recall

Presence of a foreign substance: black hair found embedded in tablet.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: MLF2401A, Exp 01/31/2026

More recalls by Macleods Pharmaceuticals Ltd

View all recalls by this company →

Other recent Class III Drug recalls